Tumor-associated dendritic cells can produce high levels of CXCL9, which promotes tumor progression by increasing programmed death-ligand 1 (PD-L1) expression through the activation of CXCR3-related signals (Marcovecchio et al., 2021). Here, CD274 is linked to neoplasm.